31 October 2017

Interrad Medical, Inc.

LGB is acting as the European placement agent in the $7 million offering of secured convertible notes by Interrad Medical, Inc. (www.securacath.com). 

The company has developed a platform technology for the stabilisation of catheters using a sub-cutaneous anchor. The UK's NICE issued guidance in favour of the use of its lead product, SecurAcath, in June. More than $5 million of notes have been issued so far. 

Recent Articles

19 May 2021

Spotlight on the New Age Consumer

The shift in shopping habits and marketing is not new, but the pandemic has clearly accelerated trends that were already in place. Read more

News & Insights

19 May 2021

Spotlight on Redx Pharma

The healthcare sector has witnessed decades of innovation and technological advancement. Read more

News & Insights

28 April 2021

The start of a supercycle?

With the UK government last year announcing that green hydrogen was to be central to the country’s ‘green industrial revolution' and the EU’s hydrogen roadmap forecasting €500bn being invested in the transition to a hydrogen-based economy by 2050, Read more

News & Insights